TOMAS MIKE 4
4 · U.S. Stem Cell, Inc. · Filed May 18, 2018
Insider Transaction Report
Form 4
TOMAS MIKE
DirectorCEO & President
Transactions
- Award
Stock Option (right to buy)
2018-05-07+20,000,000→ 58,541,284 totalExercise: $0.05Exp: 2028-05-07→ Common Stock (20,000,000 underlying)
Holdings
- 9,793
Common Stock
Footnotes (1)
- [F1]5,000,000 vest on 05/07/2019, 5,000,000 vest on 05/07/2020, 5,000,000 vest on 05/07/2021, and 5,000,000 vest on 05/07/2022.